Exchange: NASDAQ·Updated 06:50 AM EDT
BBOT logo

BBOT BridgeBio Oncology Therapeutics Inc.

$5.50
$0.02
(0.36%)
Pre-Market
Prev Close $5.52
EarningsNov 11
Mkt Cap$541.58M
Vol4,298.00

About BBOT

Bridgebio Oncology Therapeutics, Inc. engages in developing bioavailable small molecule inhibitors. It focuses on advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Ka malignancies. The company was founded on August 1, 2016 and is headquartered in South San Francisco, CA.
72

Bullish Sentiment

How do you feel about BBOT?

Advertisement|Remove ads.